Evidence map›Paper›PMID 31389184›Full record

ArticleAging cell2019

Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15.

Yuna Guo, Jessica L Ayers, Kelly T Carter, Ting Wang, Sean K Maden, Darwin Edmond, Polly Newcomb P, Christopher Li, Cornelia Ulrich, Ming Yu and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Aging cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328677 (ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis), which is not on this map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 126 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. GDF15 in aging, metabolic disease and cachexia.The journal of nutrition, health & aging · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Senescent fibroblasts drive CD8Journal of translational medicine · 2026
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yuna GuoClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0003-4466-8638
Jessica L AyersClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0002-6909-8945
Kelly T CarterClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0003-1772-9431
Ting WangClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0003-4712-6658
Sean K MadenClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0002-2212-4894
Darwin EdmondUniversity of Washington, Seattle, Washington.ORCID 0000-0002-1708-2183
Polly Newcomb PPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Christopher LiPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Cornelia UlrichPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Ming YuClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0001-8692-6135
William M GradyClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0002-0129-7809
Fred Hutch Cancer Center · USUniversity of Washington · USHuntsman Cancer Institute · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
Tumor mutation signaturesP01CA077852 · NCI · UNIVERSITY OF WASHINGTON · PI SIDOROVA, JULIA · 1999 to 2019
$26.0M
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyU01CA206110 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jane C. Figueiredo, Christopher I Li · 2016 to 2026
$18.6M
Trans-NetworkU54CA143862 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MELDRUM, DEIRDRE R. · 2009 to 2013
$8.4M
Identify and validate novel epigenetic molecular markers for colorectal neoplasmU01CA152756 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY, GUDA, KISHORE · 2010 to 2021
$6.7M
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer RecurrenceR01CA207371 · NCI · UNIVERSITY OF UTAH · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2017 to 2022
$3.9M
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.R01CA220004 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY, HALBERG, RICHARD BROTT · 2017 to 2021
$3.2M
Translational Science of Gastrointestinal Cancer Initiation and ProgressionR50CA233042 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Ming Yu · 2018 to 2026
$2.4M
(PQC1) Accelerated biological aging and colon polyp to cancer progressionR01CA194663 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY · 2015 to 2018
$1.6M
Cottrell Family FundHuntsman Cancer FoundationListwin Family FoundationNCI NIH HHS P01 CA077852NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA207371NCI NIH HHS R50 CA233042NCI NIH HHS U01 CA152756NIH HHS P01CA077852NIH HHS P30CA042014NIH HHS P30CA15704NIH HHS R01189184NIH HHS R01CA194663NIH HHS R01CA207371NIH HHS R01CA220004NIH HHS U01CA206110NIH HHS U54CA143862R.A.C.E. CharitiesRodger C. Haggitt Endowed ChairSeattle Translational Tumor ResearchW.H. Geiger Family Foundation
6 · The paper itself

Abstract

The risk of colorectal cancer (CRC) varies between people, and the cellular mechanisms mediating the differences in risk are largely unknown. Senescence has been implicated as a causative cellular mechanism for many diseases, including cancer, and may affect the risk for CRC. Senescent fibroblasts that accumulate in tissues secondary to aging and oxidative stress have been shown to promote cancer formation via a senescence-associated secretory phenotype (SASP). In this study, we assessed the role of senescence and the SASP in CRC formation. Using primary human colon tissue, we found an accumulation of senescent fibroblasts in normal tissues from individuals with advanced adenomas or carcinomas in comparison with individuals with no polyps or CRC. In in vitro and ex vivo model systems, we induced senescence using oxidative stress in colon fibroblasts and demonstrated that the senescent fibroblasts secrete GDF15 as an essential SASP factor that promotes cell proliferation, migration, and invasion in colon adenoma and CRC cell lines as well as primary colon organoids via the MAPK and PI3K signaling pathways. In addition, we observed increased mRNA expression of GDF15 in primary normal colon tissue from people at increased risk for CRC in comparison with average risk individuals. These findings implicate the importance of a senescence-associated tissue microenvironment and the secretory factor GDF15 in promoting CRC formation.

Indexed as

AgingCellular SenescenceTumor MicroenvironmentCells, CulturedColonic NeoplasmsFibroblastsGrowth Differentiation Factor 15HEK293 CellsHumansPhenotypeRNA, MessengerGDF15 protein, humanGrowth Differentiation Factor 15RNA, Messengercolon organoidscolorectal cancerGDF15microenvironmentsenescence

Identifiers

PMID31389184
PMCPMC6826139
OpenAlexW2965836614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.